Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Non-Current Deffered Revenue (2016 - 2020)

Ptc Therapeutics (PTCT) has 7 years of Non-Current Deffered Revenue data on record, last reported at $1.8 million in Q1 2020.

  • For Q1 2020, Non-Current Deffered Revenue fell 80.03% year-over-year to $1.8 million; the TTM value through Mar 2020 reached $1.8 million, down 80.03%, while the annual FY2019 figure was $3.4 million, 64.87% down from the prior year.
  • Non-Current Deffered Revenue reached $1.8 million in Q1 2020 per PTCT's latest filing, down from $3.4 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $9.7 million in Q4 2018 and bottomed at $1.6 million in Q4 2016.
  • Average Non-Current Deffered Revenue over 5 years is $5.7 million, with a median of $6.0 million recorded in 2017.
  • Peak YoY movement for Non-Current Deffered Revenue: soared 401.2% in 2017, then tumbled 80.03% in 2020.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $1.6 million in 2016, then skyrocketed by 401.2% to $8.0 million in 2017, then rose by 22.23% to $9.7 million in 2018, then plummeted by 64.87% to $3.4 million in 2019, then plummeted by 48.23% to $1.8 million in 2020.
  • Per Business Quant database, its latest 3 readings for Non-Current Deffered Revenue were $1.8 million in Q1 2020, $3.4 million in Q4 2019, and $5.5 million in Q3 2019.